← Back to Search

Behavioural Intervention

Vibrant Capsule for Anorexia

N/A
Recruiting
Research Sponsored by Laureate Institute for Brain Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
HC Inclusion criteria: Independently ambulatory
HC Inclusion criteria: Females, ages 15 to 40 years
Must not have
AN Exclusion criteria: History of esophageal disorders
HC Exclusion criteria: Pelvic floor dysfunction/defecatory disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 month, 3 month, and 6 month follow-up

Summary

This trial looks at whether people with anorexia have abnormal "gut sensations" and if those indicators are linked to consequences from the disorder.

Who is the study for?
This trial is for females aged 15-40 with anorexia nervosa, a BMI ≥ 18.5, and stable on current medications. Participants must be able to walk, have a smartphone with data, speak English, use birth control if of childbearing age, and provide consent. Exclusions include psychiatric disorders other than AN, certain medication use (affecting gut motility), significant GI disorders or surgeries affecting the gut's structure/function.
What is being tested?
The study tests whether a novel device called the Vibrant capsule can detect abnormal 'gut sensations' in individuals with anorexia nervosa and if these sensations are linked to negative outcomes of the disorder.
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort or adverse reactions related to the Vibrant capsule ingestion which is designed to assess gastrointestinal sensation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk on my own without help.
Select...
I am a female aged between 15 and 40.
Select...
I have been diagnosed with anorexia nervosa.
Select...
I am a female aged between 15 and 40.
Select...
I can walk on my own without help.
Select...
I've moved from acute care to a less intensive outpatient or residential care setting.
Select...
I am using reliable birth control methods if I can have children.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have never had esophageal disorders.
Select...
I do not have pelvic floor dysfunction or defecatory disorders.
Select...
I have never had esophageal disorders.
Select...
I have never had surgery to remove part of my intestines or weight-loss surgery.
Select...
I do not have a condition where my blood pressure drops when I stand up.
Select...
I have never had surgery to remove part of my intestines or weight-loss surgery.
Select...
I do not have a diagnosed pain disorder.
Select...
I have never had a blockage in my intestines or colon.
Select...
I am not taking any psychotropic medications.
Select...
I do not have any specific gastrointestinal conditions.
Select...
I do not have any specific gastrointestinal conditions.
Select...
I do not have a history of serious stomach or intestine problems.
Select...
I do not have a diagnosed pain disorder.
Select...
I do not use NSAIDs regularly.
Select...
I have never had severe diverticular disease.
Select...
I have not had a gastrointestinal bleed in the last 3 months.
Select...
I do not have severe stomach emptying issues.
Select...
I do not have a history of serious stomach or intestine problems.
Select...
I do not have severe stomach emptying issues.
Select...
I do not have pelvic floor dysfunction or defecatory disorder.
Select...
I do not use NSAIDs regularly.
Select...
I have never had a blockage in my intestines or colon.
Select...
I have never had serious issues with diverticular disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 month, 3 month, and 6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 month, 3 month, and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Electrogastrogram
Evoked response potential
Interoceptive precision
+2 more
Secondary study objectives
Illness status
Normalized A prime

Side effects data

From 2019 Phase 4 trial • 59 Patients • NCT04458675
6%
Other
3%
Diarrhea
3%
Abdominal pain
3%
Headache
3%
Oropharyngeal pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Capsule stimulationExperimental Treatment1 Intervention
Participants in this arm will receive gastric stimulation via the Vibrant capsule
Group II: Placebo stimulationPlacebo Group1 Intervention
Participants in this arm will receive no gastric stimulation via a placebo capsule
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibrant capsule
2021
Completed Phase 4
~370

Find a Location

Who is running the clinical trial?

Laureate Institute for Brain Research, Inc.Lead Sponsor
52 Previous Clinical Trials
5,290 Total Patients Enrolled
5 Trials studying Anorexia Nervosa
313 Patients Enrolled for Anorexia Nervosa

Media Library

Vibrant capsule (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05111977 — N/A
Anorexia Nervosa Research Study Groups: Capsule stimulation, Placebo stimulation
Anorexia Nervosa Clinical Trial 2023: Vibrant capsule Highlights & Side Effects. Trial Name: NCT05111977 — N/A
Vibrant capsule (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05111977 — N/A
~46 spots leftby Apr 2026